Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations
Clinical trial NCT02971839 · TERMINATED
Trial details
- NCT number
- NCT02971839
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-08-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.